Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Spinazzi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|September 24, 2009
Mitochondrial disorders of the nuclear genomeC Angelini, L Bello, M Spinazzi, et al.
Journal of Medical Genetics|May 29, 2007
Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2AM Fanin, L Nardetto, A C Nascimbeni, et al.
Revue Neurologique|August 26, 2023
Anti-SARS-CoV-2 (COVID-19) vaccination efficacy in patients with severe neuromuscular diseasesA Damour, P Delalande, F Cordelières, et al.
Human Mutation|June 29, 2004
Molecular diagnosis in LGMD2A: mutation analysis or protein testing?M Fanin, L Fulizio, A C Nascimbeni, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|September 24, 2009
Mitochondrial disorders of the nuclear genomeC Angelini, L Bello, M Spinazzi, et al.
Journal of Medical Genetics|May 29, 2007
Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2AM Fanin, L Nardetto, A C Nascimbeni, et al.
Revue Neurologique|August 26, 2023
Anti-SARS-CoV-2 (COVID-19) vaccination efficacy in patients with severe neuromuscular diseasesA Damour, P Delalande, F Cordelières, et al.
Human Mutation|June 29, 2004
Molecular diagnosis in LGMD2A: mutation analysis or protein testing?M Fanin, L Fulizio, A C Nascimbeni, et al.
Pageof 1